目的：分析新冠肺炎疫情下泪道探通术治疗新生儿泪囊炎日间手术模式的临床疗效，为新生儿泪囊炎泪道探通术日间手术模式的发展与推进提供理论依据。方法：回顾性分析215例行泪道探通术治疗新生儿泪囊炎日间手术管理的患儿信息，分析其治愈率、并发症、不良反应发生率，以及预约住院患儿爽约原因。结果：纳入的215例患儿均成功完成泪道探通术及日间手术管理。新生儿泪囊炎泪道探通术实施日间手术管理手术成功率高，达99.6%，术后并发症及不良反应少。预约后爽约的原因以患儿原因居多，多因患儿合并感冒、肺炎、腹泻等疾病导致全身情况不稳定而爽约或改期。结论：在新冠肺炎疫情期间，开展新生儿泪囊炎泪道探通术日间手术管理是安全有效可行的，能够降低患儿住院费用、缩短住院时间，有利于新冠肺炎疫情防控。

AIM: To analyze the clinical efficacy of neonatal dacryocystitis treated by the lacrimal passage probing(LPB)in ambulatory surgery mode during the prevalence of the COVID-19, and to provide a theoretical basis for the development and promotion of daytime operation mode of LPB in neonatal dacryocystitis.METHODS: The information of 215 cases with neonatal dacryocystitis treated by LPB with ambulatory surgery mode was analyzed retrospectively, including the cure rate, the incidence of complications and adverse reactions, as well as the reasons for not arriving at the hospital after appointment.RESULTS: All patients accomplish LPB surgery and daytime operation management successfully. The success rate of LPB for neonatal dacryocystitis with ambulatory surgery mode was 99.6%, with few postoperative complications and adverse reactions. The reason why the children did not arrive at the hospital after appointment was mainly due to the sickness being catching a cold, pneumonia, diarrhea and other diseases, otherwise, they had to cancel or postponed the appointment.CONCLUSION: In the course of the prevalence of the COVID-19, LPB in the treatment of neonatal dacryocystitis in ambulatory surgery mode is safe, effective and feasible. It can reduce hospitalization expenses, shorten hospitalization time, and is more conducive to the prevention and control of COVID-19, which is worthy of popularization and application.

四川省卫生和计划生育委员会科研课题(No.17PJ551); 遂宁市中心医院院级科研课题(No.2019y36)